RECRUITING

AnovaOS Network Powered Patient Registry

Talk to us

Conditions

Infectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Circulatory SystemDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Servicesinfectious disease, cancer/oncology, neurology, immunology, cardiology

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Official Title

AnovaOS Network Powered Patient Registry

Quick Facts

Study Start:2021-09-01
Study Completion:2026-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05013944

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years old or older;
  2. * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
  3. * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
  4. * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
  5. * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
  6. * Anticipated additional follow up with the registry once per year.
  1. * Subjects who do not meet the inclusion criteria for the study;
  2. * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Contacts and Locations

Study Contact

Christopher Beardmore
CONTACT
+1 (224) 218-2408
chris@anovaevidence.com

Principal Investigator

Martin Walsh
STUDY_DIRECTOR
Anova Enterprises, Inc
Christopher Beardmore
PRINCIPAL_INVESTIGATOR
Anova Enterprises, Inc

Study Locations (Sites)

Anova Enterprises, Inc.
Arlington Heights, Illinois, 60005
United States

Collaborators and Investigators

Sponsor: Anova Enterprises, Inc

  • Martin Walsh, STUDY_DIRECTOR, Anova Enterprises, Inc
  • Christopher Beardmore, PRINCIPAL_INVESTIGATOR, Anova Enterprises, Inc

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-01
Study Completion Date2026-08-31

Study Record Updates

Study Start Date2021-09-01
Study Completion Date2026-08-31

Terms related to this study

Keywords Provided by Researchers

  • infectious disease, cancer/oncology, neurology, immunology, cardiology

Additional Relevant MeSH Terms

  • Infectious Disease
  • Neoplasms
  • Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)
  • Endocrine, Nutritional and Metabolic Diseases (E00-E89)
  • Mental and Behavioural Disorders
  • Diseases of the Nervous System
  • Diseases of the Eye and Adnexa
  • Diseases of the Ear and Mastoid Process
  • Diseases of the Circulatory System
  • Diseases of the Respiratory System
  • Diseases of the Digestive System
  • Diseases of the Skin and Subcutaneous Tissue
  • Diseases of the Musculoskeletal System and Connective Tissue
  • Diseases of the Genitourinary System
  • Pregnancy, Childbirth and the Puerperium
  • Certain Conditions Originating in the Perinatal Period
  • Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)
  • Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified
  • Injury, Poisoning and Certain Other Consequences of External Causes
  • External Causes of Morbidity and Mortality
  • Factors Influencing Health Status and Contact With Health Services